Volume 21 (2023): Issue 3.5 (Mar 2023): Abstracts from the NCCN 2023 Annual Conference

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
Young Investigator Awards
Best Practices in Implementation and Use of Clinical Practice Guidelines
BPI23-007: Characterizing Opioid Prescribing Trends of Medical Oncologists From 2013–2019
BPI23-008: Accelerating Adoption of Hypofractionation in Breast Cancer Through Clinical Pathways and Peer Review
BPI23-009: Oncologists’ Perceptions of a Novel Superoxide Dismutase Mimetic (Avasopasem Manganese) for Treating Severe Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer
BPI23-010: The Benefits of a Clinically Based Individualized Exercise Oncology Program on Health Care Utilization in Patients With Malignancies
BPI23-011: Real-World Study of First-Line Treatment Patterns in HR+/HER2– Metastatic Breast Cancer (MBC) at a Tertiary Care Cancer Institute
BPI23-012: Real-World Frequency of ECHO Monitoring and Incidence of Anti-HER2 Therapy Related Cardiac Events in HER2+ Breast Cancer Patients
BPI23-013: Comparison of Modified Patient-Reported Paper G8 and EPIC G4 + 4 With Clinician-Reported Standard G8 to Screen Frailty in Elderly Patients With Cancer
BPI23-014: Elevation in the Creatinine With Niraparib: True or False?
BPI23-016: Interventional Pain Management in Outpatient Setting for Cancer Patients: A Review of Literature
Bioinformatics/Information Technology Sciences
Clinical Oncology
CLO23-024: Evaluating the Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Patients With Non–Small Cell Lung Cancer (NSCLC)
CLO23-025: Comparison of Outcomes Using NCCN Classification in Two Concurrent Phase III Trials in Intermediate and High Risk Prostate Cancer: Long-Term Data
CLO23-029: An APP-Run Lymphadenopathy Clinic: The Cleveland Clinic Experience
CLO23-030: MC200402-Single-Arm Phase 2 Study of the FGFR Inhibitor Futibatinib (Futi) in Combination With Pembrolizumab (Pem) in Patients With FGF19 Expressing Advanced or Metastatic Hepatocellular Carcinoma (aHCC)
CLO23-032: Treatment of HER2+ Breast Cancer: A Retrospective of Disease Prognosis With Loss of HER2 Amplification on Residual Disease After Neoadjuvant Treatment in a Community Hospital Setting
CLO23-036: A Rare Case of Intratubular Cytoplasmic AL Amyloidosis in a Patient Without Multiple Myeloma
CLO23-040: Electrocardiographic Findings in Cancer Patients Receiving Chemotherapy From the Colombian Coffee Triangle Region
CLO23-041: Cardiovascular Event Risk Following Androgen Deprivation Therapy Initiation by Personal History of Cardiovascular Events
CLO23-042: Clinical Outcomes of Radical Radiotherapy With or Without Chemotherapy in Inoperable Locally Advanced Squamous Cell Carcinoma of Oral Cavity
CLO23-043: Optimal Interval Between Immune Therapy and Targeted Therapy With Sotorasib in Patients With KRAS G12C Mutant Non–Small Cell Lung Cancer
CLO23-045: A Prospective Interventional Study to Assess the Response of Systemic Chemotherapy in Aggressive, Recurrent Giant Cell Tumor
CLO23-046: Pooled Outcomes of Anti-BRAF Agents in Advanced Stage Colorectal Cancer
CLO23-047: Ivosidenib as a Novel Treatment for Patients With Isocitrate Dehydrogenase-1 Positive Advanced Colon Cancer
CLO23-048: Disparities in Outcomes of Chemotherapy-Related Febrile Neutropenia Patients: A Nationwide Study of Hospitalizations
CLO23-049: An Unusual Case Presentation of Severe Idiopathic Multicentric Castleman Disease (iMCD)
CLO23-050: Total Neoadjuvant Chemotherapy Followed by HIPEC and Curative Surgery in Treatment of Locally Advanced Gastric Cancer
CLO23-051: Real-World Use of Neratinib in Patients With HER2-Positive Early-Stage Breast Cancer Following Prior Ado-Trastuzumab Emtansine (T-DM1) or Dual HER2 Blockade With Pertuzumab Plus Trastuzumab
CLO23-052: Risk Factors and Prognosis of Stroke in Gynecologic Cancer
CLO23-057: The Influence of Operability Status on Outcomes in Patients With T4a Larynx Cancer: An Institutional Experience
CLO23-058: Targeted Axillary Dissection Post Primary Chemotherapy: Data Analysis From a Single Multidisciplinary Unit in South Africa
CLO23-059: HDR-ICR Brachytherapy With Solo Anesthesia Administration as a Resource-Effective and Patient-Safe Method in Cancer Cervix
CLO23-060: Extranodal Presentation of Double Hit High Grade B Cell Lymphoma
CLO23-061: Evaluation of Adding Neck Dissection to N0 Head and Neck Cancer Patients
CLO23-062: Pediatric Metastatic Pulmonary Adenocarcinoma
CLO23-063: Impact of Socio-Economic Disparity on Survival of HER 2 Neu (+) Breast Cancer Brain Metastasis Patients With Chemotherapy: A SEER Study
CLO23-064: PD-1/PD-L1 Inhibitors in Advanced and Metastatic Esophageal Carcinoma: An Updated Meta-Analysis of Randomized Controlled Trials
CLO23-065: Dosimetric Comparison of Hypofractionation With Concomitant Boost Versus Sequential Boost Following Breast-Conserving Surgery in Early Stage Breast Cancer Patients
CLO23-066: Risk of Secondary Malignancies After Platinum-Based Chemotherapy in Testicular Seminoma Patients: A Population-Based Study
CLO23-068: Effectiveness and Toxicity of Cetuximab With Concurrent Radiotherapy in Locally Advanced Cutaneous Squamous Cell Skin Cancer: A Case Series
Correlative/Genomic
Epidemiology/Risks/Prevention
EPR23-076: Demographic Changes of Expanded 2021 Lung Cancer Screening Guidelines in a Large National Database
EPR23-077: Incidence and Mechanisms of Coexisting Hematological Malignancies: Chronic Lymphocytic Leukemia and Chronic Myeloid Leukemia—A Retrospective Review
EPR23-078: Analyzing Trends in the Incidence and Mortality of Esophageal Cancer in the United States: A 15-Year Population-Based Study
EPR23-079: Cervical Cancer Screening Among the Rural Indians—A Community Based Prospective Study
EPR23-080: Oral Cancer Screening Among the Rural Indians—A Community Based Prospective Study
EPR23-082: Patient Awareness of Elevated Breast Cancer Risk After Routine Screening Mammogram and Risk Notification
EPR23-083: Non-Squamous, Metastatic Non–Small Cell Lung Cancer: Retrospective c-Met Overexpression Testing, Patient Characteristics, and Treatment Patterns
EPR23-084: Bimodal Distribution of Osteosarcoma: A Thing of the Past? Comparative Analysis From Surveillance, Epidemiology, and End Results (SEER) and National Inpatient Sample (NIS)
EPR23-085: Prevalence of Substance Use in Cancer Patients at a 5-Year Difference: A Cross-Sectional Study From Nationally Representative Population
EPR23-086: Knowing the Lymphomas of the Legal Amazon: How Do They Differ?
EPR23-087: Perceived Risk and Uptake of Healthy Lifestyle Behaviors for Breast Cancer Prevention Among High-Risk Women
Outcomes and Health Services Research
HSR23-088: Laparoscopic Complete Mesocolic Excision Versus Standard Laparoscopic Right Hemicolectomy in Egyptian Right Colon Cancer
HSR23-089: Patient Reported Quality of Life (QoL) Among Adults Admitted for Oncology Care in Abu Dhabi, United Arab Emirates (UAE)
HSR23-090: Racial Differences in Outcomes of Osimertinib in Patients With EGFR-Positive Non–Small Cell Lung Cancer in a Real World US Population
HSR23-092: Real-World Analysis Examining Cost of Early Disease Progression Among Patients With Epidermal Growth Factor Receptor Mutated Metastatic Non–Small Cell Lung Cancer
HSR23-093: Lung Cancer Treatment Utilization Trends: 2019-2021
HSR23-094: Uterine Cancer (UC) on the Rise in the United States (US): One of the Largest Racial Disparities in Oncology
HSR23-095: Outcomes of Patients With Pancreatic Cancer Undergoing Duodenal Stent Placement: A Population-Based Study
HSR23-096: COVID-19 Impact and Psychosocial Well-Being Among Adults Living With Cancer: A Longitudinal Analysis
HSR23-098: Extensive and Dynamic Signs and Symptoms Prior to Cancer Diagnoses
HSR23-100: The Potential Clinical Impact of a Multi-Cancer Early Detection Test for Individuals With Missing Cancer Stage Information
HSR23-101: Characteristics and Outcomes of Patients Treated With Selpercatinib in the Real-World: A Retrospective Study Using US Claims Databases
HSR23-102: Diagnosis of Metastatic Non–Small Cell Lung Cancer During Hospitalization: Missed Opportunity for Optimal Supportive Care?
HSR23-103: Pancreatic Cancer: The Impact of Early Connectivity and Coordination of Care on Retention and Time to Treat
HSR23-104: How Pancreatic Patients Choose Their Cancer Center: An Analysis of Factors That Influence Retention
HSR23-105: Real-World Dosing Patterns in Patients With Anaplastic Lymphoma Kinase Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) Treated With Brigatinib in the Front-Line (FL) Setting in the United States: A Claims Database Analysis
HSR23-106: Real-World Study of Disease-Free Survival and Associated Patient Characteristics in Early-Stage Non–Small Cell Lung Cancer (NSCLC): A Retrospective Observational Study
HSR23-107: Real-World Study of Biomarker Testing and Treatment Patterns in Patients With Metastatic Castration-Resistant Prostate Cancer in the United States (US): A Physician Survey
HSR23-108: Physician Preferences on Biomarker Testing in Newly-Diagnosed Metastatic NSCLC Patients Who Had Insufficient Tumor Tissue
HSR23-109: Real-World Combination Use of Mogamulizumab With Other Therapies Among Patients With Mycosis Fungoides and Sézary Syndrome
HSR23-110: Immune Checkpoint Inhibitor (ICI) Treatment After Progression on Anti–PD-1 Therapy in Advanced Melanoma: A Systematic Review of the Literature
HSR23-111: Real-World EGFR Testing in Patients With Surgically Resected Stage I-III Non–Small Cell Lung Cancer (NSCLC) in US Community Oncology Practices
HSR23-112: Disease Burden and Treatment Patterns in Patients Diagnosed With HER2- Metastatic Gastric/Gastroesophageal Junction Cancer (mG/GEJC)
HSR23-113: Patient and Provider Perspectives on How COVID-19 Impacted Melanoma Care Delivery
HSR23-114: Clinical Characteristics and Outcomes of US Extensive Stage Small Cell Lung Cancer (ES-SCLC) Patients Not Receiving Guideline Preferred Regimens
HSR23-115: Stress-Related Biofeedback Responses After Reiki and Sound Healing Therapies for Breast Cancer Survivors
HSR23-116: Emotional and Mental Health Support Needs of Adolescent and Young Adult (AYA) Colorectal Cancer Patients
HSR23-117: First-Line (1L) Systemic Therapy in Patients (pts) With Advanced Non–Small Cell Lung Cancer (aNSCLC) at Community Settings in the United States (US)
HSR23-118: Assessment of Physician Treatment Preferences for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
HSR23-119: Real-World Duration of Venetoclax Treatment for Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia (CLL/SLL)
HSR23-120: Real-World Observations Show Beneficial Outcomes in Patients With NSCLC Treated With Pembrolizumab for More Than 2 Years
HSR23-121: Assessment of Sustained MRD Negativity and Reversion in Real-World Multiple Myeloma Patients Using NGS (clonoSEQ Assay)
Pre-Clinical Oncology
Quality Improvement
QIM23-126: Positive Quality Intervention in Action: Implementation and Value in Practice
QIM23-127: Using NCCN Distress Thermometer to Screen Cancer Patients on an Inpatient Oncology Unit
QIM23-128: Improving Multidisciplinary Thoracic Tumor Board With a Case Submission Tool
QIM23-129: Impact of the COVID Pandemic on Oncology Education, Mentorship, and Networking—A National Survey
QIM23-130: Committing to Resiliency: Transforming Burnout to Resilience at a National Cancer Institute (NCI) Comprehensive Cancer Center
QIM23-131: A Retrospective Review of Myelodysplastic Syndrome Management (MDS) at Watson Clinic LLP: From Diagnosis to Primary Course of Treatment
QIM23-132: Do EHR-Embedded Clinical Decision Support Tools Reduce Variation in Care? A Pre and Post-Implementation Comparison of Regimen Ordering Variation at a Multi-Site Community Cancer Clinic
QIM23-133: Aligning NCCN Criteria With Testing Workflows Using a Novel Database Application (Criterion™)
QIM23-135: Improving Management of Treatment Side Effects Through Chemotherapy Care Kit Delivery in Vietnam
QIM23-136: Nurse Navigators Charted a Course for Equitable Care in Multiple Myeloma: Simplifying QI to Measure the Impact of Accredited Education
QIM23-137: Improving Hematology-Oncology Education in Internal Medicine Residency—A Single Institution Quality Improvement Project
QIM23-138: Using the Electronic Health Record (EHR) to Capture Structured Oncology Data in Real-Time at the Point-of-Care: A Mayo Clinic Comprehensive Cancer Center (MCCCC) Pilot Study
QIM23-139: Creating a Fellowship Curriculum: Clinical Trial Patient Conversations
QIM23-140: Health Care Satisfaction Among Cancer Patients Undergoing Radiotherapy: A Tunisian Center Experience
QIM23-141: An APP Initiated Telehealth Visit to Reduce Oncology Patient Readmissions: Lessons Learned
QIM23-142: Evaluation of a Standardized Approach to Hypersensitivity/Infusion Reaction Management in a Large Ambulatory Oncology Center
QIM23-143: The Impact of Tailored Lean Approach in Optimization of Infusion Scheduling Process in an NCI Designated Cancer Center
QIM23-144: A Race Against Time in Cancer Diagnosis: A QI Study
QIM23-146: Using a Multi-Modal Approach in Addressing Identified Barriers to Improve Lung Cancer Screening in Northeast Georgia—An Interim Report
QIM23-147: Predictors of Delay for Initial Oncology Referral and Treatment at a Safety-Net Hospital: A Single Center Analysis
QIM23-148: Effectiveness of a Provider Education Intervention for Increasing Human Papillomavirus Vaccine Uptake at Pediatric Clinics Within a Safety-Net Health System
QIM23-149: Patient-Level Barriers to the Global Care for Familial Adenomatous Polyposis: Lessons From a Large Brazilian Family
QIM23-150: Electronic Health Record Alerts Compared to Chart Review for Lung Cancer Screening Eligibility
  • Collapse
  • Expand